1[1]Hasslacher C, Ritz E, Wahl P, et al. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant, 1989, 4: 859
2[2]UK Prospective Diabetic Study(UKPDS) Group. Intensive blood-sugar control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33). Lancet, 1998,352:837
3[3]Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet, 1994, 344:14
4[4]Maclure M, Dormuth C, Naumann T, et al. Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia [see comments] . Lancet, 1998, 352: 943
5[5]Nielsen FS, Rossing P, Gall MA, et al. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes,1994,43:1108
6[6]Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study [see comments]. N Engl J Med, 2000, 342: 905
7[7]Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group [see comments]. Lancet, 1998, 351: 1755
8[8]UK Prospective Diabetic Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BJM, 1998, 317:713
3Acourciere Y, Beanger A. Long-term comparison of valsartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy ( J ). Kidney Int,2000 ;58 (2) :762.
4[3]Pirart J.Diabetes mellitns and its degenerative eomplieations a prospective study of 4400 patients observed between 1947 and 1973[J].Diabetes/Metabolism Reviews,1997,3:97.
5[4]UKP respective,Diabetic Study(UKPDS)Group.Intensive blood-sugar control with sulphony lureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS33)[J].Lancet,1998,352:837.
6Herget-Rosenthal S,Poppen D,Husing J,et al.Prognosticvalue of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis[J].Clin Chem,2004,50(3):552-558.
7Arnidharka VR,Kwon C,Steven G.Serum cystatin C is superior to serum creatinine as a marker of kindney function:a meta-analysis[J].Am J kidney Dis,2002,40(2):221-226.
8Coll E,Wirtz O,He L,et al.Serum cystatin C as a new marker for noninvasive eatimation of glomerular fitration rate and as a marker for erarly impairment[J].AmJ Kidney Dis,2000,36(1):29-34.
9Pirart,J.Diabetes mellitus and its degenerative complications A prospective study of 4,400 patients observed between 1947 and 1973[J].Diabetes/Metabolism Reviews,1997,3:97.
10UKP respective, Diabetic Study(UKPDS)Group.Intensive blood-sugar control with sulphony lureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS33)[J].Lancet,1998,352:837.
